PARTNERING STRATEGY AND SUPPORT: SEARCH AND EVALUATION

THE CLIENT

A large global biopharma, with marketed assets in lung cancer and near term expected approval in GI cancers, sought to identify an optimal commercialisation partner for near-term synergies to generate immediate revenue

THE BUSINESS CHALLENGE

The client wanted a third-party review and validation to find the optimal asset (marketed or near approval). They sought asset opportunities that offered the optimal strategic benefit for both parties

OUR APPROACH

We undertook a search and evaluation process to identify assets in areas/phases of interest and screened for the asset’s scientific/clinical and commercial opportunities and risks. We supplemented the assessment with secondary and primary research, leveraging our deep understanding of the area

THE RESULTS

Our team strategically guided the large biopharma to key assets and companies, and enabled the client to have better informed interactions at major medical and partnering conferences